Evidence map›Paper›PMID 36230118›Full record

ArticleFoods (Basel, Switzerland)2022

Entomoculture: A Preliminary Techno-Economic Assessment.

Reina Ashizawa, Natalie Rubio, Sophia Letcher, Avery Parkinson, Victoria Dmitruczyk, David L Kaplan

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Reina AshizawaDepartment of Biology, Tufts University, Medford, MA 02155, USA.
Natalie RubioDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.ORCID 0000-0001-6702-1509
Sophia LetcherDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Avery ParkinsonDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Victoria DmitruczykSchool of Life Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.ORCID 0000-0002-9577-7669
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.ORCID 0000-0002-9245-7774
Tufts University · USMcMaster University · CA

Funding

United States Department of Agriculture 2021-69012-35978
6 · The paper itself

Abstract

Cultured meat, or the practice of growing meat from cell culture, has been experiencing rapid advances in research and technology as the field of biotechnology attempts to answer the call to fight climate change and feed a growing global population. A major hurdle for cell-based meat products entering the market in the near-future is their price. The complex production facilities required to make such products will require advanced bioreactor systems, resources such as energy and water, and a skilled labor force, among other factors. The use of insect cells in this process is hypothesized to address some of these costs due to the characteristics that make them more resilient in cell culture when compared to traditional livestock-derived cells. To address the potential for cost savings by utilizing insect cells in the cultivation of protein-enriched foods, here we utilized a techno-economic assessment model. Three different insect cell lines were used in the model. The results indicate that insect cell lines offer potential to significantly reduce the cost per kilogram of cell cultivated meat, along with further opportunities to optimize production processes through technological advances and scaling.

Indexed as

cell-based meatcultured meatinsect cellstechnoeconomic assessment

Identifiers

PMID36230118
PMCPMC9564176
OpenAlexW4303644858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.